Found: 90
Select item for more details and to access through your institution.
Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists—Secondary publication.
- Published in:
- Cancer Science, 2024, v. 115, n. 2, p. 672, doi. 10.1111/cas.15975
- By:
- Publication type:
- Article
Novel endoscopic duodenal observation protocol based on Seven Pictures Rule for detecting duodenal neoplasms during esophagogastroduodenoscopy: Prospective observational study.
- Published in:
- Digestive Endoscopy, 2024, v. 36, n. 2, p. 154, doi. 10.1111/den.14591
- By:
- Publication type:
- Article
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09).
- Published in:
- Targeted Oncology, 2023, v. 18, n. 3, p. 359, doi. 10.1007/s11523-023-00961-x
- By:
- Publication type:
- Article
Income Change One Year after Confirmed Cancer Diagnosis and Its Associated Factors in Japanese Patients.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 23, p. 15992, doi. 10.3390/ijerph192315992
- By:
- Publication type:
- Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
- By:
- Publication type:
- Article
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 7, p. 717, doi. 10.1093/jjco/hyac073
- By:
- Publication type:
- Article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1649, doi. 10.1007/s10637-021-01125-2
- By:
- Publication type:
- Article
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2025, doi. 10.1007/s10147-021-02004-9
- By:
- Publication type:
- Article
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 753, doi. 10.1007/s11523-021-00845-y
- By:
- Publication type:
- Article
Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1125, doi. 10.1002/onco.13816
- By:
- Publication type:
- Article
The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato‐Biliary Oncology Group.
- Published in:
- Cancer Reports, 2021, v. 4, n. 2, p. 1, doi. 10.1002/cnr2.1323
- By:
- Publication type:
- Article
A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 6, p. 2088, doi. 10.1002/cam4.3813
- By:
- Publication type:
- Article
Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy following FOLFIRINOX in Patients with Unresectable Pancreatic Cancer: A Single-Institution, Retrospective Analysis.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 58, doi. 10.1159/000517244
- By:
- Publication type:
- Article
FMS‐like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 314, doi. 10.1111/cas.14693
- By:
- Publication type:
- Article
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
- Published in:
- Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
- By:
- Publication type:
- Article
Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
- By:
- Publication type:
- Article
Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
- By:
- Publication type:
- Article
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234314
- By:
- Publication type:
- Article
Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 6, p. 1115, doi. 10.1007/s10147-020-01646-5
- By:
- Publication type:
- Article
Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 531, doi. 10.1007/s10147-019-01593-w
- By:
- Publication type:
- Article
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 614, doi. 10.1007/s10147-019-01600-0
- By:
- Publication type:
- Article
Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 1, doi. 10.1007/s10147-019-01485-z
- By:
- Publication type:
- Article
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1214, doi. 10.1007/s10147-019-01465-3
- By:
- Publication type:
- Article
Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 9, p. 2875, doi. 10.1111/cas.14117
- By:
- Publication type:
- Article
Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 5, p. 1385, doi. 10.1245/s10434-019-07252-8
- By:
- Publication type:
- Article
Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 2, p. 255, doi. 10.1007/s12282-018-0905-1
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 1, p. 63, doi. 10.1111/ajco.13050
- By:
- Publication type:
- Article
Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 1, p. 138, doi. 10.1007/s10120-018-0845-7
- By:
- Publication type:
- Article
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
- By:
- Publication type:
- Article
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 792, doi. 10.1007/s10120-018-0797-y
- By:
- Publication type:
- Article
A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 811, doi. 10.1007/s10120-018-0815-0
- By:
- Publication type:
- Article
Multicenter, randomized, controlled trial of S‐1 monotherapy versus S‐1 and interferon‐α combination therapy for hepatocellular carcinoma with extrahepatic metastases.
- Published in:
- Hepatology Research, 2018, v. 48, n. 9, p. 717, doi. 10.1111/hepr.13067
- By:
- Publication type:
- Article
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type <italic>RAS</italic> gene: the JACCRO CC-14 study.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 3, p. 490, doi. 10.1007/s10147-017-1228-5
- By:
- Publication type:
- Article
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 5, p. 434, doi. 10.1093/jjco/hyy033
- By:
- Publication type:
- Article
Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
- Published in:
- Oncology, 2018, v. 94, n. 5, p. 289, doi. 10.1159/000486624
- By:
- Publication type:
- Article
A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202).
- Published in:
- 2018
- By:
- Publication type:
- journal article